We are live on ! Find out more
DY

Dowling & Yahnke Portfolio holdings

AUM $2.15B
1-Year Est. Return 10.82%
This Fund
S&P 500
This Quarter Est. Return
+20.41%
1 Year Est. Return
-10.82%
3 Year Est. Return
+34.82%
5 Year Est. Return
+71.23%
10 Year Est. Return
AUM
$1.19B
AUM Growth
+$154M
Cap. Flow
-$28.7M
Cap. Flow %
-2.4%
Top 10 Hldgs %
26.24%
Holding
314
New
23
Increased
125
Reduced
138
Closed
14

Sector Composition

Rank Sector Weight
1 Miscellaneous 25.33%
2 Technology 16.06%
3 Healthcare 15.24%
4 Financials 10.11%
5 Consumer Staples 9.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DLS icon
276
WisdomTree International SmallCap Dividend Fund
DLS
$1.09B
$261K 0.02%
4,696
-20
-0.4% -$1.06K
IYE icon
277
iShares US Energy ETF
IYE
$1.83B
$259K 0.02%
12,940
-66,160
-84% -$1.3M
IJS icon
278
iShares S&P Small-Cap 600 Value ETF
IJS
$8.28B
$258K 0.02%
4,292
-86
-2% -$4.82K
IWS icon
279
iShares Russell Mid-Cap Value ETF
IWS
$15.8B
$258K 0.02%
3,365
+46
+1% +$3.35K
IYH icon
280
iShares US Healthcare ETF
IYH
$3.74B
$253K 0.02%
5,860
+235
+4% +$9.92K
MUB icon
281
iShares National Muni Bond ETF
MUB
$45.5B
$251K 0.02%
+2,178
New +$247K
APD icon
282
Air Products & Chemicals
APD
$68.6B
$245K 0.02%
1,015
-73
-7% -$16.7K
IWN icon
283
iShares Russell 2000 Value ETF
IWN
$14.5B
$245K 0.02%
+2,518
New +$229K
EOG icon
284
EOG Resources
EOG
$75.2B
$239K 0.02%
4,722
-3,685
-44% -$179K
ICE icon
285
Intercontinental Exchange
ICE
$91.1B
$235K 0.02%
+2,562
New +$235K
SCHB icon
286
Schwab US Broad Market ETF
SCHB
$44.7B
$235K 0.02%
+19,218
New +$222K
MSI icon
287
Motorola Solutions
MSI
$80.4B
$232K 0.02%
1,656
-400
-19% -$56.6K
WEC icon
288
WEC Energy
WEC
$34.6B
$224K 0.02%
2,553
-100
-4% -$9.02K
EW icon
289
Edwards Lifesciences
EW
$52B
$213K 0.02%
+3,081
New +$219K
NVS icon
290
Novartis
NVS
$292B
$202K 0.02%
+2,308
New +$199K
GRFS
291
Grifois
GRFS
$5.23B
$200K 0.02%
10,955
IVE icon
292
iShares S&P 500 Value ETF
IVE
$50.2B
$200K 0.02%
1,850
-405
-18% -$43K
CMRX
293
DELISTED
Chimerix, Inc.
CMRX
$115K 0.01%
37,013
BMY.RT
294
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$101K 0.01%
28,124
FBIO icon
295
Fortress Biotech
FBIO
$92.4M
$54K ﹤0.01%
1,333
BCRX icon
296
BioCryst Pharmaceuticals
BCRX
$2.51B
$52K ﹤0.01%
11,000
TCON
297
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$40K ﹤0.01%
1,023
+273
+36% +$10.8K
ADMS
298
DELISTED
Adamas Pharmaceuticals
ADMS
$33K ﹤0.01%
13,000
ATNM icon
299
Actinium Pharmaceuticals
ATNM
$31.7M
$8K ﹤0.01%
762
RGLS
300
DELISTED
Regulus Therapeutics
RGLS
$8K ﹤0.01%
+1,200
New +$7.85K

Similar funds

Dowling & Yahnke's Q2 2020 Portfolio in Review

As of Q2 2020, Dowling & Yahnke held 314 positions worth $1.19B, up 15% from $1.04B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Dowling & Yahnke's Q2 2020 filing shows 23 new, 125 increased, 138 reduced and 14 closed positions. Its largest new stake was Otis Worldwide: 17,872 shares worth $1.02M. The largest sale was Qualcomm, an estimated $16.1M.

By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, down from 27% a quarter earlier, followed by Technology and Healthcare.

  • Dowling & Yahnke's largest Q2 2020 buy was Otis Worldwide: 17,872 shares worth $1.02M.
  • Dowling & Yahnke added most to State Street Energy Select Sector SPDR ETF in Q2 2020, an estimated $3.21M increase.
  • Dowling & Yahnke's biggest Q2 2020 reduction was Qualcomm, cutting an estimated $16.1M.
  • Dowling & Yahnke fully exited Raytheon Company in Q2 2020, selling an estimated $3.21M.
  • Dowling & Yahnke's ten largest holdings make up 26% of its $1.19B portfolio in Q2 2020.
  • Dowling & Yahnke opened 23 new positions and closed 14 in Q2 2020.
  • Dowling & Yahnke's portfolio value rose 15% quarter-over-quarter to $1.19B.

Based on Dowling & Yahnke's 13F filing for Q2 2020, filed 31 Jul 2020.